SCH708980
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SCH708980, covering 2013-08-28 to 2013-08-28. Get the full timeline:
Most recent: Clinical Trial Update: SCH708980 With and Without AmBisome for Visceral Leishmaniasis [Phase 1, Phase 2]